As of 2026-01-04, the Relative Valuation of Xphyto Therapeutics Corp (XPHY.CN) is (1.22) CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.50 CAD, the upside of Xphyto Therapeutics Corp based on Relative Valuation is -345.8%.
The range of the Relative Valuation is (0.97) - (1.41) CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 7.9x - 11.5x | 9.9x |
| Forward P/E multiples | 7.9x - 11.7x | 9.9x |
| Fair Price | (0.97) - (1.41) | (1.22) |
| Upside | -296.6% - -385.0% | -345.8% |
| Date | P/E |